FDA weighs loosening peptide bans after safety warnings
The FDA is taking its first step toward possibly allowing seven peptides that are currently restricted due to safety concerns, with an advisory panel to discuss their use for various conditions. Kennedy Jr. backs broader access, but experts caution that more study is needed to ensure safety, noting past FDA warnings about peptides like BPC-157.